News

1. Alcanza Clinical Research Announces Launch of Enspire Clinical Research in Illinois

   Expanding Alcanza's Upper Midwest footprint, the new Peoria facility delivers early-stage trial capabilities, onsite PBMC lab support, and efficient study execution for sponsors, CROs, and surrounding communities.

2. Amerigo Scientific Launches Advanced Lipid-Based Transfection Reagents to Empower Stem Cell Research

   Amerigo Scientific launched a comprehensive portfolio of lipid‑based transfection reagents tailored for stem cell research and engineering.

3. Creative Biolabs Launches Upgraded Lambda and M13 Phage Library Platforms to Accelerate Biotherapeutic Discovery

   Creative Biolabs announced the launch of its upgraded lambda and M13 phage library platforms, empowering researchers to accelerate breakthroughs in genomics and therapeutic development.

4. Marquis Who's Who Honors Dr. Pete Patterson for Expertise in Health Care

   Dr. Pete Patterson is celebrating 55 years of dedicated service in the health care industry

5. Alfa Cytology Launches Custom 3D Tumor Models and Organoid Model Research Services for Cancer Drug Discovery

   Alfa Cytology supports a more physiologically relevant drug development evaluation system by providing customized 3D tumor models and organoid research services.

6. Creative Biolabs Enhances iPSC Differentiation Portfolio to Accelerate Neuroscience and Regenerative Medicine Research

   Creative Biolabs announces the highlight of its comprehensive induced pluripotent stem cell (iPSC) differentiation services designed to support cutting-edge biomedical research.

7. Creative Diagnostics Strengthens Preclinical Support with Advanced Coronavirus Animal Model Services for Antiviral Research

   Creative Diagnostics announces the release of its Coronavirus Animal Model services to help scientists to evaluate the pathogenicity and transmissibility of Coronavirus.

8. CD Bioparticles Launches Innovative Organoid Culture Tools to Advance 3D Disease Modeling and Drug Discovery

   CD Bioparticles announces the launch of its comprehensive line of Organoid Culture Tools.

9. Creative Biolabs Advances Oncology Frontiers with Next-Generation Synthetic Carbohydrate-Based Cancer Vaccine Platforms

   Creative Biolabs has announced a strategic expansion of its cancer vaccine research platforms, focusing on the sophisticated design and synthesis of tumor-associated carbohydrate antigens (TAGAs).

10. Creative Biolabs Unveils Integrated Microfluidic Solutions Synergizing Neuron-on-a-Chip and Advanced Cell Sorting

    Creative Biolabs' one-stop microfluidic platform accelerates biomedical breakthroughs by streamlining chip innovation for faster, scalable, and physiologically relevant discoveries.